Advertisement

Topics

"Amgen Allergan Receive Positive CHMP Opinion Biosimilar Bevacizumab" Drugs and Medication Database

15:47 EDT 25th June 2018 | BioPortfolio

Here are the most relevant "Amgen Allergan Receive Positive CHMP Opinion Biosimilar Bevacizumab" Drugs and Medications that we have found in our database.

More Information about "Amgen Allergan Receive Positive CHMP Opinion Biosimilar Bevacizumab" on BioPortfolio

We have published hundreds of Amgen Allergan Receive Positive CHMP Opinion Biosimilar Bevacizumab news stories on BioPortfolio along with dozens of Amgen Allergan Receive Positive CHMP Opinion Biosimilar Bevacizumab Clinical Trials and PubMed Articles about Amgen Allergan Receive Positive CHMP Opinion Biosimilar Bevacizumab for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Amgen Allergan Receive Positive CHMP Opinion Biosimilar Bevacizumab Companies in our database. You can also find out about relevant Amgen Allergan Receive Positive CHMP Opinion Biosimilar Bevacizumab Drugs and Medications on this site too.

Showing "Amgen Allergan Receive Positive CHMP Opinion Biosimilar Bevacizumab" Drugs and Medications 1–25 of 83

Relevant

Refresh classic [Allergan, Inc.]

REFRESH Classic

Refresh liquigel [Allergan, Inc.]

REFRESH LIQUIGEL

Refresh celluvisc [Allergan, Inc.]

REFRESH CELLUVISCLubricant Eye Drops

Refresh plus [Allergan, Inc.]

REFRESH PLUSLubricant Eye Drops

Probably Relevant

Refresh optive sensitive [Allergan, Inc.]

REFRESH OPTIVE™ Sensitive

Refresh lacri-lube [Allergan, Inc.]

Refresh p.m. [Allergan, Inc.]

Refresh optive [Allergan, Inc.]

REFRESH OPTIVE

Refresh redness relief [Allergan, Inc.]

REFRESH REDNESS RELIEF

Vectibix [Amgen Inc]

These highlights do not include all the information needed to use Vectibix safely and effectively. See full prescribing information for Vectibix. Vectibix (panitumumab)Injection for intravenous infusionInitial U.S. Approval: 2006

Lubrifresh p.m. [Major Pharaceuticals]

Artificial Tears Ointment Drug Facts

M.d. forte glycare perfection [Allergan, Inc.]

GLYCARE PERFECTION GEL

Alocril [Allergan, Inc.]

ALOCRIL (nedocromil sodium ophthalmic solution) 2%

Refresh tears [Allergan, Inc.]

Ocufen [Allergan, Inc.]

OCUFEN (flurbiprofen sodium ophthalmic solution, USP) 0.03%

Lastacaft [Allergan, Inc.]

These highlights do not include all the information needed to use LASTACAFT safely and effectively. See full prescribing information for LASTACAFT. LASTACAFT (alcaftadine ophthalmic solution) 0.25%Initial U.S. Approval: 2010

Refresh optive advanced [Allergan, Inc.]

Liquitears [Major Pharmaceuticals]

Artificial Tears Solution Drug Facts

Possibly Relevant

Fluoroplex [Allergan, Inc.]

FLUOROPLEX (fluorouracil) 1%Topical Cream

Bleph-10 [Allergan, Inc.]

BLEPH-10(sulfacetamide sodium ophthalmic solution, USP) 10%

Restasis [Allergan, Inc.]

RESTASIS (cyclosporine ophthalmic emulsion) 0.05%

M.d. forte aftercare environmental protection sunscreen spf 30 [Allergan, Inc.]

AFTERCARE ENVIRONMENTAL PROTECTION SUNSCREEN

Elestat [Allergan, Inc.]

These highlights do not include all the information needed to use ELESTAT safely and effectively. See full prescribing information for ELESTAT. ELESTAT (epinastine HCl ophthalmic solution) 0.05%Initial U.S. Approval: 2003

Nplate [Amgen Inc]

These highlights do not include all the information needed to use Nplate safely and effectively. See full prescribing information for Nplate. Nplate (romiplostim)For subcutaneous injection Initial U.S. Approval: 2008

Vivite daily facial moisturizer with sunscreen spf 30 [Allergan, Inc.]

VIVITE Daily Facial Moisturizer with Sunscreen SPF 30



Advertisement
Quick Search
Advertisement
Advertisement